GlassScriptPhysician profile
Altaf Girach
NPI 1801982491
$4,380.33
in general payments reported to CMS, 2019-2025
40 companies · $675 in 2025
The $675 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $229 · 2021: $1,188 · 2022: $687 · 2023: $539 · 2024: $693 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $521.60 | 2019-2024 | Lokelma, Breztri, Airsupra |
| Lilly USA, LLC | $452.85 | 2019-2025 | Mounjaro, Kisunla, Amyvid |
| Janssen Pharmaceuticals, INC | $418.29 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $251.46 | 2022-2025 | |
| Astellas Pharma US INC | $232.53 | 2019-2022 | |
| Lundbeck LLC | $229.92 | 2024-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $225.46 | 2023-2025 | Rexulti, Nuedexta |
| Glaxosmithkline, LLC. | $180.89 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $175.95 | 2019-2024 | |
| Pfizer INC. | $163.66 | 2019-2024 | |
| Vanda Pharmaceuticals INC. | $161.56 | 2021-2023 | Hetlioz |
| Mylan Specialty L.P. | $116.82 | 2021-2024 | Yupelri |
| Exact Sciences Corporation | $105.31 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $102.89 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $100.14 | 2019-2024 | Eliquis |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Altaf Girach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.